Health Care Supplies

Align

Lululemon

Financial Analysis

LULU

ALGN

China surged again. Now the key growth driver.

LULU: Comeback or Flash in the Pan?

Align Technology Showcases Latest Advances in Integrated Digital Orthodontics and Previews 2026 Innovation at AAO Annual Session

Align Technology Announces $200 Million Stock Repurchase Program

Align released FY2026 Q1 earnings on April 29 After-Market (EST), actual revenue USD 1.04 B (forecast USD 1.021 B), actual EPS USD 1.57 (forecast USD 1.49)

Align Technology Reports Q1 2026 Earnings

Align Technology Q1 Earnings Beat Estimates

Align to release FY2026 Q1 earnings on April 29 After-Market EST, forecast revenue USD 1.022 B, EPS USD 1.49

Align Technology Sees a Significant Increase in Short Interest in March

SG Americas Securities LLC Significantly Boosts Holdings in Align Technology

Align Technology expects 2025 fiscal year revenue of $4 billion and plans to hold an annual shareholders' meeting

Elliott Investment Management Takes Large Stake in Align Technology Plans Contact

Capital International Increased Holdings of Align Technology in Q3

Align Technology Launches iTero Lumina™ Pro Intraoral Scanner

Henry Schein Collaborates with Align Technology to Integrate iTero™ Scanner

DDD Partners LLC Increases Holdings in Align Technology in Q3

FactSet Ups ALGN-US EPS Forecast for 2026

Align released FY2025 earnings on February 4 After-Market EST, actual revenue USD 4.035 B (forecast USD 4.04 B), actual EPS USD 5.65 (forecast USD 5.695)

Align released FY2025 Q4 earnings on February 4 After-Market EST, actual revenue USD 1.048 B (forecast USD 1.033 B), actual EPS USD 1.8864 (forecast USD 1.83)

Align Technology Reports Stronger-than-Expected Q4 Earnings

Align to Release FY2025 Earnings on February 4, 2026, After-Market EST; Forecast Revenue USD 4.03 B, EPS USD 5.695

Massachusetts Financial Services Co. increased its stake in Align Technology Inc. by 54.1% in Q3

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

American International Group Inc. (AIG) shares fell 1.06% to $77.53 on Tuesday, underperforming compared to competitors. The S&P 500 Index and Dow Jones Industrial Average also declined. AIG's stock is 11.35% below its 52-week high of $87.46. Trading volume was 3.3 million, below the 50-day average of 4.4 million.

MarketWatch Automated

American International Group

S&P 500

Dow Jones Industrial Average

Chubb

Cigna

Progressive

Factset Research

American International Group Inc. Stock Underperforms Tuesday When Compared To Competitors

Dr. Michael McClain discusses in HelloNation how Invisalign and braces can treat various orthodontic issues, including bite alignment, crowding, and spacing. The article highlights common problems like overbites, crossbites, and open bites, explaining that both treatments can effectively address these concerns. It emphasizes the importance of proper diagnosis and individualized care for optimal outcomes, noting that treatment can begin at different ages and contributes to long-term oral health.

Unusual Whales

iShares US Medical Devices

SPDR S&P Health Equip

Health Care Select Sector SPDR

In HelloNation, Orthodontics Expert Dr. Michael McClain Details What Orthodontic Problems Invisalign and Braces Can Fix

Align Technology Inc. (ALGN) shares fell 2.04% to $157.25 on Friday, marking the third consecutive day of losses. The stock is now 24.51% below its 52-week high of $208.31. In comparison, competitors Zimmer Biomet Holdings Inc. rose 1.27%, while Dentsply Sirona Inc. dropped 3.27%. Overall, the stock market faced a downturn, with the S&P 500 and Dow Jones Industrial Average declining by 1.24% and 1.07%, respectively.

Zimmer Biomet

Dentsply Sirona

Align Technology Inc. Stock Underperforms Friday When Compared To Competitors

Align Technology previewed new digital orthodontic tools and reaffirmed its 2026 guidance at the AAO 2026 Annual Session. The company reported higher sales, net income, and earnings per share in Q1 compared to the previous year. Align's shift to fully digital, 3D-printed solutions aims to enhance its integrated platform, despite facing challenges from pricing competition and demand pressures. Analysts project varying revenue growth rates, with a potential fair value of $201.69, indicating a 25% upside from the current price. Investors are advised to consider both growth potential and competitive risks.

Simplywall

Is Align Technology (ALGN) Quietly Redefining Its Moat With Fully Digital, 3D‑Printed Orthodontics?

Align Technology Inc. (ALGN) shares fell 2.44% to $161.75 on Wednesday, underperforming against competitors like Zimmer Biomet Holdings Inc. and Dentsply Sirona Inc. The S&P 500 Index rose 0.58%, while the Dow Jones Industrial Average decreased by 0.14%. Align's stock is currently 22.35% below its 52-week high of $208.31 reached on July 29. Trading volume was 636,387, significantly below the 50-day average of 1.2 million shares.

Align Technology Inc. Stock Underperforms Wednesday When Compared To Competitors

Sequoia Financial Advisors LLC increased its stake in Align Technology, Inc. (NASDAQ:ALGN) by 320.1% in Q4, owning 7,986 shares valued at $1.25 million. Other institutional investors also raised their stakes, with Capital International Investors boosting holdings by 88.6%. Analysts have set new price targets for Align Technology, with a consensus target of $205.85. The stock opened at $165.79, with a market cap of $11.87 billion and a P/E ratio of 27.82. Align reported $2.58 EPS for the last quarter, exceeding estimates.

Market Beat

Bank of America

Invesco

UBS Group AG

Morgan Stanley

Barclays

Mizuho Financial

Mizuho Financial Group, Inc.

Jefferies Financial

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

Sequoia Financial Advisors LLC Has $1.25 Million Stock Position in Align Technology, Inc. $ALGN

Align Technology Inc. (ALGN) shares fell 2.47% to $164.61 on a day when the S&P 500 and Dow Jones both rose 0.19%. The stock is 20.98% below its 52-week high of $208.31. Compared to competitors, Align outperformed Zimmer Biomet Holdings Inc. (down 3.34%) and Dentsply Sirona Inc. (down 0.82%). Trading volume was 1.1 million, slightly below the 50-day average of 1.2 million.

Align Technology Inc. Stock Outperforms Competitors Despite Losses On The Day

Align Technology (ALGN) reported a Q1 2026 earnings beat and product updates, but its stock declined 3.19% in one day and 4.33% over a week. The stock is currently viewed as 8.9% overvalued with a fair value of $154.62, while a DCF model suggests a deeper value at $275.69. Investors are cautioned about potential competition and consumer spending impacts. The article encourages reviewing both sides of the investment narrative and exploring additional stock opportunities.

Assessing Align Technology (ALGN) Valuation After Q1 2026 Earnings Beat And Product Updates

Align(ALGN.US)